C

China National Medicines Corp Ltd
SSE:600511

Watchlist Manager
China National Medicines Corp Ltd
SSE:600511
Watchlist
Price: 34.44 CNY 0.06% Market Closed
Market Cap: 26B CNY
Have any thoughts about
China National Medicines Corp Ltd?
Write Note

China National Medicines Corp Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

China National Medicines Corp Ltd
Revenue Peer Comparison

Comparables:
1099
601607
600998
000963
Q
301015

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
C
China National Medicines Corp Ltd
SSE:600511
Revenue
ÂĄ50.3B
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
17%
Sinopharm Group Co Ltd
HKEX:1099
Revenue
ÂĄ590.3B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
13%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Revenue
ÂĄ267.1B
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
12%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Revenue
ÂĄ148B
CAGR 3-Years
7%
CAGR 5-Years
10%
CAGR 10-Years
15%
Huadong Medicine Co Ltd
SZSE:000963
Revenue
ÂĄ41.2B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
9%
Q
Qingdao Baheal Medical Inc
SZSE:301015
Revenue
ÂĄ7.6B
CAGR 3-Years
9%
CAGR 5-Years
16%
CAGR 10-Years
N/A

See Also

What is China National Medicines Corp Ltd's Revenue?
Revenue
50.3B CNY

Based on the financial report for Jun 30, 2024, China National Medicines Corp Ltd's Revenue amounts to 50.3B CNY.

What is China National Medicines Corp Ltd's Revenue growth rate?
Revenue CAGR 10Y
17%

Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for China National Medicines Corp Ltd have been 4% over the past three years , 4% over the past five years , and 17% over the past ten years .

Back to Top